Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction

被引:95
作者
Croft, SA
Samani, NJ
Hampton, KK
Steeds, RP
Channer, KS
Daly, ME
机构
[1] Univ Leicester, Dept Cardiol, Leicester, Leics, England
[2] Univ Sheffield, Div Genomic Med, Sheffield, S Yorkshire, England
[3] Royal Hallamshire Hosp, Dept Cardiol, Sheffield S10 2JF, S Yorkshire, England
关键词
myocardial infarction; genetics; platelets;
D O I
10.1161/hc3801.096397
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Back-ground-Glycoprotein (GP) VI plays a crucial role in platelet activation and aggregation. We investigated whether polymorphic variation at the Gl? VI locus confers an increased risk of myocardial infarction (MI). Methods and Results-Coding and 5' and 3' non-coding regions of the Gl? VI gene were analyzed by polymerase chain reaction and conformation sensitive gel electrophoresis in 21 healthy subjects. Ten dimorphisms, 5 of which predicted amino acid substitutions (T13254C, A19871G, A21908G, A22630T, C22644A), were identified. Two core haplotypes involving 7 dimorphisms (C10781A and G10873A and all those predicting amino acid substitutions) were apparent. The contribution of the T13254C dimorphism, which predicted the substitution of serine 219 by proline, to risk of MI was assessed in 525 patients with acute MI and 474 controls, all aged < 75 years. The allelic odds ratio (OR) for MI associated with the 13254C allele was 1.16 (95% CI, 0.91 to 1.46; P=0.23). Compared with corresponding control subgroups, the 13254CC genotype was more common among cases who were female (OR, 4.52; 95% CI, 1.23 to 16.64; P=0.029), nonsmokers (OR, 2.50; 95% CI, 0.98 to 6.38; P=0.048), aged greater than or equal to 60 years (OR, 6.48; 95% CI, 1.47 to 28.45; P=0.009) or carried the beta -fibrinogen -148T allele associated with increased fibrinogen levels (OR, 10.49; 95% CI, 1.32 to 83.42; P=0.02). In logistic regression analysis that took other cardiovascular risk factors into account, the interactions of GP VI genotype with age (P=0.005) and beta -fibrinogen genotype (P=0.035) remained significant. Conclusions-The Gl? VI 13254CC genotype increases the risk of MI, particularly in older individuals, and the interaction of the GP VI 13254C allele with other candidate risk alleles may accentuate this risk.
引用
收藏
页码:1459 / 1463
页数:5
相关论文
共 11 条
  • [1] The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcαR and the natural killer receptors
    Clemetson, JM
    Polgar, J
    Magnenat, E
    Wells, TNC
    Clemetson, KJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (41) : 29019 - 29024
  • [2] The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction
    Croft, SA
    Hampton, KK
    Sorrell, JA
    Steeds, RP
    Channer, KS
    Samani, NJ
    Daly, ME
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) : 771 - 776
  • [3] Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain
    Gibbins, JM
    Okuma, M
    Farndale, R
    Barnes, M
    Watson, SP
    [J]. FEBS LETTERS, 1997, 413 (02) : 255 - 259
  • [4] Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily
    Jandrot-Perrus, M
    Busfield, S
    Lagrue, AH
    Xiong, XM
    Debili, N
    Chickering, T
    Le Couedic, JP
    Goodearl, A
    Dussault, B
    Fraser, C
    Vainchenker, W
    Villeval, JL
    [J]. BLOOD, 2000, 96 (05) : 1798 - 1807
  • [5] GENETIC SUSCEPTIBILITY TO DEATH FROM CORONARY HEART-DISEASE IN A STUDY OF TWINS
    MARENBERG, ME
    RISCH, N
    BERKMAN, LF
    FLODERUS, B
    DEFAIRE, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (15) : 1041 - 1046
  • [6] CHARACTERISTICS AFFECTING FIBRINOLYTIC-ACTIVITY AND PLASMA FIBRINOGEN CONCENTRATIONS
    MEADE, TW
    CHAKRABARTI, R
    HAINES, AP
    NORTH, WRS
    STIRLING, Y
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1979, 1 (6157): : 153 - 156
  • [7] HEMOSTATIC FUNCTION AND ISCHEMIC-HEART-DISEASE - PRINCIPAL RESULTS OF THE NORTHWICK-PARK-HEART-STUDY
    MEADE, TW
    BROZOVIC, M
    CHAKRABARTI, RR
    HAINES, AP
    IMESON, JD
    MELLOWS, S
    MILLER, GJ
    NORTH, WRS
    STIRLING, Y
    THOMPSON, SG
    [J]. LANCET, 1986, 2 (8506) : 533 - 537
  • [8] SANTORO SA, 1995, THROMB HAEMOSTASIS, V74, P813
  • [9] THOMAS AE, 1991, THROMB HAEMOSTASIS, V65, P487
  • [10] Influence of the-675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden
    Visanji, JM
    Seargent, J
    Tahri, D
    Croft, SA
    Makris, M
    Preston, FE
    Peake, IR
    Daly, ME
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 135 - 138